AstraZeneca Buying Drug Developer Alexion For $39 Billion in Top Business News- News18.com published on December 12, 2020 leave a reply Pharmaceutical company AstraZeneca says it is buying U.S. drug developer Alexion in a deal worth $39 billion. from Top Business News- News18.com https://ift.tt/37e6RzT Tweet Share Share Share Share Previous Post India's Factory Output Shows Signs of V-Shaped Recovery, Performs Almost Seven Times Better than Last Month Next Post AstraZeneca To Buy Alexion For $39 Billion To Expand In Immunology post written by: Rohit Related PostsWalmart Sacks Around 50 Executives From Real Estate Division in India: ReportThe firings mostly affected executives in the company's real estate division because the growth in the wholesale model has not been that robust, two of the sour… Continue ReadingAramco's 'Greenshoe Option' Pushes IPO to Record $29.4 BillionThe oil and gas company, which is majority owned by the state, began publicly trading on the local Saudi Tadawul exchange on December 11. from Top Business New… Continue ReadingInfosys Shares Climb Over 4% After Brokerages Give Thumbs Up to Q3 ResultsInfosys on Friday after market hours said Q3 consolidated net profit jumped 11% compared with the previous quarter to Rs 4,457 crore (up 23.5% year-on-year) on … Continue ReadingIndia is in Talks with Mongolia and Russia for Importing Coking Coal: Dharmendra PradhanThe minister said the Centre is looking to import coking coal, a raw material for making steel, at a reasonable price as the country has set a target to produce… Continue ReadingSensex Hits Lifetime High, Zooms Over 250 Points; Infosys Leads Gains at 4%Infosys was the top gainer, rising over 3 per cent, after the IT services major Infosys on Friday reported a 23.7 per cent rise in consolidated net profit at Rs… Continue Reading
0 comments: